Pathak Jyotishman, Kiefer Richard C, Chute Christopher G
Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Stud Health Technol Inform. 2013;192:682-6.
By nature, healthcare data is highly complex and voluminous. While on one hand, it provides unprecedented opportunities to identify hidden and unknown relationships between patients and treatment outcomes, or drugs and allergic reactions for given individuals, representing and querying large network datasets poses significant technical challenges. In this research, we study the use of Semantic Web and Linked Data technologies for identifying drug-drug interaction (DDI) information from publicly available resources, and determining if such interactions were observed using real patient data. Specifically, we apply Linked Data principles and technologies for representing patient data from electronic health records (EHRs) at Mayo Clinic as Resource Description Framework (RDF), and identify potential drug-drug interactions (PDDIs) for widely prescribed cardiovascular and gastroenterology drugs. Our results from the proof-of-concept study demonstrate the potential of applying such a methodology to study patient health outcomes as well as enabling genome-guided drug therapies and treatment interventions.
从本质上讲,医疗保健数据极为复杂且体量庞大。一方面,它为识别患者与治疗结果之间隐藏的未知关系,或给定个体的药物与过敏反应之间的关系提供了前所未有的机遇,然而表示和查询大型网络数据集带来了重大的技术挑战。在本研究中,我们探讨使用语义网和关联数据技术从公开可用资源中识别药物相互作用(DDI)信息,并确定是否使用真实患者数据观察到了此类相互作用。具体而言,我们应用关联数据原则和技术将梅奥诊所电子健康记录(EHR)中的患者数据表示为资源描述框架(RDF),并识别广泛使用的心血管和胃肠病药物的潜在药物相互作用(PDDI)。我们概念验证研究的结果证明了应用这种方法来研究患者健康结果以及实现基因组引导的药物治疗和治疗干预的潜力。